NOVEL THERAPY FOR MARIJUANA ADDICTION
Award amount
$99,884Program and phase
SBIR · Phase IAward year
2006Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MURTY PHARMACEUTICALS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- DNJBTJ3XBQM6
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Nasal Delivery of Ondansetron for Treatment of Alcoholism
- DEVELOPMENT OF PLACEBO MARIJUANA CIGARETTES
- ISOLATION OF POTENTIAL ANTI-CANCER DRUGS BY SUPERCRITICAL FLUID EXTRACTION
- TRANSDERMAL DELIVERY OF TETRAHYDROCANNABINOL
- Not Available
Research funding history
12 SBIR/STTR records share this UEI (1996–2008). Reported award amounts total $4,330,600. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services